P53 Activation Promotes Maturational Characteristics of Pluripotent Stem Cell‐Derived Cardiomyocytes in 3‐Dimensional Suspension Culture Via FOXO‐FOXM1 Regulation
Open Access
- 2 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e033155
Abstract
Background: Current protocols generate highly pure human induced pluripotent stem cell–derived cardiomyocytes (hiPSC‐CMs) in vitro that recapitulate characteristics of mature in vivo cardiomyocytes. Yet, a risk of arrhythmias exists when hiPSC‐CMs are injected into large animal models. Thus, understanding hiPSC‐CM maturational mechanisms is crucial for clinical translation. Forkhead box (FOX) transcription factors regulate postnatal cardiomyocyte maturation through a balance between FOXO and FOXM1. We also previously demonstrated that p53 activation enhances hiPSC‐CM maturation. Here, we investigate whether p53 activation modulates the FOXO/FOXM1 balance to promote hiPSC‐CM maturation in 3‐dimensional suspension culture. Methods and Results: Three‐dimensional cultures of hiPSC‐CMs were treated with Nutlin‐3a (p53 activator, 10 μM), LOM612 (FOXO relocator, 5 μM), AS1842856 (FOXO inhibitor, 1 μM), or RCM‐1 (FOXM1 inhibitor, 1 μM), starting 2 days after onset of beating, with dimethyl sulfoxide (0.2% vehicle) as control. P53 activation promoted hiPSC‐CM metabolic and electrophysiological maturation alongside FOXO upregulation and FOXM1 downregulation, in n=3 to 6 per group for all assays. FOXO inhibition significantly decreased expression of cardiac‐specific markers such as TNNT2. In contrast, FOXO activation or FOXM1 inhibition promoted maturational characteristics such as increased contractility, oxygen consumption, and voltage peak maximum upstroke velocity, in n=3 to 6 per group for all assays. Further, by single‐cell RNA sequencing of n=2 LOM612‐treated cells compared with dimethyl sulfoxide, LOM612‐mediated FOXO activation promoted expression of cardiac maturational pathways. Conclusions: We show that p53 activation promotes FOXO and suppresses FOXM1 during 3‐dimensional hiPSC‐CM maturation. These results expand our understanding of hiPSC‐CM maturational mechanisms in a clinically‐relevant 3‐dimensional culture system.Keywords
This publication has 55 references indexed in Scilit:
- Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytesBioorganic & Medicinal Chemistry, 2022
- Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivoSeminars in Cell & Developmental Biology, 2021
- Single-cell analysis reveals the purification and maturation effects of glucose starvation in hiPSC-CMsBiochemical and Biophysical Research Communications, 2021
- Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Tp53 Suppression Promotes Cardiomyocyte Proliferation during Zebrafish Heart RegenerationCell Reports, 2020
- Regulation of FOXO Factors in Mammalian Cells2018
- Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damageDNA Repair, 2016
- Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem CellsCell Metabolism, 2016
- The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage ResponseCell, 2014
- DNA damage response to the Mdm2 inhibitor Nutlin-3Biochemical Pharmacology, 2010